Moneycontrol
HomeNewsWorldCoronavirus: US reports fourth case of infection of unknown origin
Trending Topics

Coronavirus: US reports fourth case of infection of unknown origin

The latest case is a boy under 18 in Washington State who tested "presumptive positive", local authorities said without releasing further details about the patient.

February 29, 2020 / 14:58 IST
Story continues below Advertisement

US health officials reported on February 28 a fourth case of novel coronavirus of unknown origin, indicating the disease was spreading in the country.

The latest case is a boy under 18 in Washington State who tested "presumptive positive", local authorities said without releasing further details about the patient.

Story continues below Advertisement

He is currently in home isolation in Snohomish County. The high school he attends will be shut until March 3 while it is deep cleaned, the Washington State Department of Health said.

In neighbouring Oregon, authorities said Friday an adult who had had contact with people at an elementary school had been hospitalized and was also considered "presumptive positive."

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show